DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,238,606 | +2.9% | 9,023 | -0.4% | 0.23% | +5.5% |
| Q2 2023 | $2,174,640 | -7.2% | 9,061 | -2.6% | 0.22% | -11.1% |
| Q1 2023 | $2,344,224 | -7.0% | 9,301 | -2.1% | 0.24% | -9.6% |
| Q4 2022 | $2,521,225 | +2.2% | 9,499 | -0.6% | 0.27% | -4.6% |
| Q3 2022 | $2,468,000 | -5.8% | 9,556 | -7.6% | 0.28% | +5.6% |
| Q2 2022 | $2,621,000 | -15.5% | 10,340 | -2.2% | 0.27% | -1.1% |
| Q1 2022 | $3,101,000 | -11.8% | 10,570 | -1.1% | 0.27% | -9.1% |
| Q4 2021 | $3,515,000 | +7.8% | 10,683 | -0.2% | 0.30% | -2.9% |
| Q3 2021 | $3,260,000 | +11.8% | 10,708 | -1.4% | 0.31% | +8.9% |
| Q2 2021 | $2,916,000 | +20.4% | 10,865 | +1.0% | 0.28% | +14.2% |
| Q1 2021 | $2,422,000 | -2.5% | 10,760 | -3.7% | 0.25% | -4.3% |
| Q4 2020 | $2,483,000 | +6.3% | 11,179 | +3.1% | 0.26% | -5.1% |
| Q3 2020 | $2,335,000 | +20.1% | 10,847 | -1.3% | 0.27% | +12.4% |
| Q2 2020 | $1,944,000 | +5.2% | 10,993 | -17.7% | 0.24% | -10.4% |
| Q1 2020 | $1,848,000 | -11.6% | 13,353 | -1.9% | 0.27% | +0.7% |
| Q4 2019 | $2,090,000 | +7.4% | 13,615 | +1.0% | 0.27% | +3.1% |
| Q3 2019 | $1,946,000 | -0.7% | 13,475 | -1.8% | 0.26% | -1.1% |
| Q2 2019 | $1,960,000 | +264.3% | 13,716 | +236.4% | 0.26% | +76.5% |
| Q1 2019 | $538,000 | +25.7% | 4,077 | -1.6% | 0.15% | +6.4% |
| Q4 2018 | $428,000 | -9.3% | 4,142 | -4.6% | 0.14% | -1.4% |
| Q3 2018 | $472,000 | -4.8% | 4,342 | -13.6% | 0.14% | -11.8% |
| Q2 2018 | $496,000 | -21.8% | 5,024 | -22.4% | 0.16% | -17.9% |
| Q1 2018 | $634,000 | +5.5% | 6,476 | 0.0% | 0.20% | +5.4% |
| Q4 2017 | $601,000 | +5.8% | 6,476 | -2.3% | 0.19% | -2.6% |
| Q3 2017 | $568,000 | -5.0% | 6,626 | -6.5% | 0.19% | -7.7% |
| Q2 2017 | $598,000 | -0.7% | 7,085 | +0.7% | 0.21% | -3.7% |
| Q1 2017 | $602,000 | -27.8% | 7,036 | -34.3% | 0.22% | -30.6% |
| Q4 2016 | $834,000 | -6.8% | 10,716 | -6.2% | 0.31% | -9.1% |
| Q3 2016 | $895,000 | -26.4% | 11,426 | -5.1% | 0.34% | -27.1% |
| Q2 2016 | $1,216,000 | +2.6% | 12,040 | -3.6% | 0.47% | -4.9% |
| Q1 2016 | $1,185,000 | +0.6% | 12,491 | -1.5% | 0.49% | -4.8% |
| Q4 2015 | $1,178,000 | -74.1% | 12,681 | -76.2% | 0.52% | -75.5% |
| Q3 2015 | $4,541,000 | -0.3% | 53,288 | +0.2% | 2.11% | -2.0% |
| Q2 2015 | $4,553,000 | +0.7% | 53,192 | -0.1% | 2.15% | +3.4% |
| Q1 2015 | $4,521,000 | -1.1% | 53,252 | -0.1% | 2.08% | +2.3% |
| Q4 2014 | $4,570,000 | +12.2% | 53,315 | -0.6% | 2.03% | +6.5% |
| Q3 2014 | $4,074,000 | -3.5% | 53,615 | 0.0% | 1.91% | -3.0% |
| Q2 2014 | $4,221,000 | +10.7% | 53,615 | -1.8% | 1.97% | +12.5% |
| Q1 2014 | $3,812,000 | – | 54,580 | – | 1.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |